Home/Filings/4/0001209191-23-010921
4//SEC Filing

Holmlin R. Erik 4

Accession 0001209191-23-010921

CIK 0001411690other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 7:23 PM ET

Size

8.5 KB

Accession

0001209191-23-010921

Insider Transaction Report

Form 4
Period: 2023-02-15
Holmlin R. Erik
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-15+1,400,0001,400,000 total
    Exercise: $1.63Exp: 2033-02-14Common Stock (1,400,000 underlying)
  • Award

    Common Stock

    2023-02-15+300,000841,615 total
Holdings
  • Common Stock

    (indirect: By IRA)
    5,025
Footnotes (3)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
  • [F2]Includes 1,443 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 1,616 shares acquired under the ESPP on December 10, 2022.
  • [F3]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

Issuer

Bionano Genomics, Inc.

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001579988

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 7:23 PM ET
Size
8.5 KB